Sort
30,917 grants matching “tumor microenvironment”
Nano-therapeutics Reprogramming of Immunosuppressive Myeloid Cells Potentiate Radiotherapy for Glioblastoma
$366,000Peng Zhang · Northwestern University At Chicago · R37 · FY2022 · CA
Mechanisms of lincDUSP Oncogenic Effects in Colon Cancer
$366,000Ahmad M Khalil · Case Western Reserve University · R01 · FY2018 · CA
Enhancing anti-EGFR Therapeutic Efficacy in Inflammatory Breast Cancer
$366,000Naoto T Ueno · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Tumor-associated neutrophils in human lung cancer
$366,000Evgeniy Eruslanov · University Of Pennsylvania · R01 · FY2016 · CA
Developing Novel Therapeutic Approaches Targeting Macrophages in GBM
$366,000Y. Alan Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
$366,000Don Lynn Gibbons · University Of Tx Md Anderson Can Ctr · R37 · FY2020 · CA
A novel pathway to overcome resistance to immunotherapy in melanoma
$366,000Diana Nora Vaz Saleiro · Northwestern University At Chicago · R01 · FY2025 · CA
Uncovering Mechanisms of Regulation and Dependency on Fatty Acid Oxidation in MYC-Driven Tumors
$366,000Andrei Goga · University Of California, San Francisco · R01 · FY2018 · CA
Tumor-associated neutrophils in human lung cancer
$366,000Evgeniy Eruslanov · University Of Pennsylvania · R01 · FY2017 · CA
INVESTIGATING TUMOR INITIATION AND INVASION IN PREMALIGNANT BREAST CANCER WITH SPATIAL SINGLE CELL GENOMICS
$366,000Nicholas Navin · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Regulation of lung cancer metastasis through transcriptional control of the Golgi apparatus
$366,000Jonathan M Kurie · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
$366,000Don Lynn Gibbons · University Of Tx Md Anderson Can Ctr · R37 · FY2022 · CA
14-3-3tau drives estrogen receptor loss and breast cancer progression
$366,000Weei-Chin Lin · Baylor College Of Medicine · R01 · FY2023 · CA
Role of KMT2D and aberrant enhancers in modulating tumor microenvironment in melanoma
$366,000Kunal Rai · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Developing Novel Therapeutic Approaches Targeting Macrophages in GBM
$366,000Y. Alan Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Off-the-shelf engineered NK cells for the treatment of AML
$366,000Katy Rezvani · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Role of KMT2D and aberrant enhancers in modulating tumor microenvironment in melanoma
$366,000Kunal Rai · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Enhancing anti-EGFR Therapeutic Efficacy in Inflammatory Breast Cancer
$366,000Naoto T Ueno · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Tumor-associated neutrophils in human lung cancer
$366,000Evgeniy Eruslanov · University Of Pennsylvania · R01 · FY2018 · CA
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
$366,000Don Lynn Gibbons · University Of Tx Md Anderson Can Ctr · R37 · FY2018 · CA
INVESTIGATING TUMOR INITIATION AND INVASION IN PREMALIGNANT BREAST CANCER WITH SPATIAL SINGLE CELL GENOMICS
$366,000Nicholas Navin · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Tumor-associated neutrophils in human lung cancer
$366,000Evgeniy Eruslanov · University Of Pennsylvania · R01 · FY2020 · CA
14-3-3tau drives estrogen receptor loss and breast cancer progression
$366,000Weei-Chin Lin · Baylor College Of Medicine · R01 · FY2025 · CA
Nano-therapeutics Reprogramming of Immunosuppressive Myeloid Cells Potentiate Radiotherapy for Glioblastoma
$366,000Peng Zhang · Northwestern University At Chicago · R37 · FY2025 · CA
Developing Novel Therapeutic Approaches Targeting Macrophages in GBM
$366,000Y. Alan Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA